Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Volitionrx Ltd as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −3 vs. Q2 2023
- Shares held
- 6.31M
- +22.9K (+0.4%) vs. Q2 2023
- Total value
- $4.35M
- −$4.39M (−50.3%) vs. Q2 2023
- New holders
- 3
- 5 more added
- Sold out
- 6
- 8 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 1 | $1 | 0.00% | −16,913−100.0% | Reduced |
| Qube Research & Technologies Ltd | 2 | $1 | 0.00% | +2 | New |
| GWM Advisors LLC | 200 | $138 | 0.00% | −500−71.4% | Reduced |
| Allworth Financial LP | 200 | $138 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 265 | $183 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 320 | $220 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 439 | $302 | 0.00% | +125+39.8% | Added |
| Bank of America Corp | 1,000 | $689 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 1,000 | $741 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,876 | $1.29K | 0.00% | −9,031−82.8% | Reduced |
| Newbridge Financial Services Group, Inc. | 2,500 | $1.72K | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 4,000 | $2.76K | 0.00% | 00.0% | Unchanged |
| Founders Capital Management | 4,000 | $2.76K | 0.00% | 00.0% | Unchanged |
| Hartford Financial Management Inc. | 5,000 | $3.44K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,031 | $5.53K | 0.00% | −4,119−33.9% | Reduced |
| Sensible Money, LLC | 10,000 | $6.89K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 10,624 | $7.32K | 0.01% | +10,624 | New |
| Charles Schwab Investment Management Inc | 15,384 | $10.6K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 21,169 | $14.6K | 0.00% | −361−1.7% | Reduced |
| Jane Street Group, LLC | 22,174 | $15.3K | 0.00% | +22,174 | New |
| Two Sigma Securities, LLC | 28,151 | $19.4K | 0.00% | +12,262+77.2% | Added |
| Spectrum Asset Management, Inc. (NB/CA) | 55,596 | $38.3K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 89,546 | $61.7K | 0.00% | +19,454+27.8% | Added |
| State Street Corp | 123,923 | $85.4K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 176,100 | $121.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 210,325 | $144.9K | 0.00% | −7,880−3.6% | Reduced |
| Geode Capital Management, LLC | 538,441 | $371.1K | 0.00% | +73,227+15.7% | Added |
| Vanguard Group Inc | 542,444 | $373.7K | 0.00% | +22,046+4.2% | Added |
| BlackRock Inc. | 552,583 | $380.7K | 0.00% | −15,443−2.7% | Reduced |
| Lagoda Investment Management, L.P. | 3,882,850 | $2.68M | 1.76% | −46,260−1.2% | Reduced |
| DFPG Investments, LLC | 0 | $0 | 0.00% | −25,138−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −6,317−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,363−100.0% | Sold out |
| CarsonAllaria Wealth Management, Ltd. | 0 | $0 | 0.00% | −2,265−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −406−100.0% | Sold out |
| Adirondack Retirement Specialists, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Cowen Prime Advisors LLC | – | – | – | – | Not filed |